3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
6
Colorectal Neoplasms
5
Neoplasms
4
Malnutrition
3
Lung Neoplasms
3
Diarrhea
3
Uterine Cervical Neoplasms
2
Stomach Neoplasms
2
Mucositis
2
Inflammation
2
Enteritis
2
Chalazion
2
Carcinoma, Hepatocellular
2
Thyroid Neoplasms
1
Squamous Intraepithelial Lesions
1
Smoldering Multiple Myeloma
1
Radiation Injuries
1
Psychological Well-Being
1
Psoriasis Vulgaris
1
Polycystic Ovary Syndrome
1
Periampullary Carcinoma Nos
1
Pelvic Neoplasms
1
Pelvic Inflammatory Disease
1
Papillomavirus Infections
1
Ovarian Neoplasms
1
Neoplasms, Second Primary
1
Muscle Invasive Bladder Cancer (MIBC)
1
Multiple Myeloma
1
Motor Activity
1
Monoclonal Gammopathy of Undetermined Significance
1
Interventions
Specimen Handling
2
Radiotherapy
2
Iohexol
2
Gemcitabine
2
spartalizumab
1
sodium thiosulfate
1
liposomal doxorubicin
1
X-Rays
1
Vorinostat
1
Surgical Procedures, Operative
1
Sunitinib
1
Solutions
1
Saline Solution
1
Re-Irradiation
1
Radiotherapy, Image-Guided
1
Radiosurgery
1
Probiotics
1
Platinum
1
Particle Accelerators
1
Pafolacianine
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Magnetic Resonance Imaging
1
Lidocaine
1
Ketamine
1
Injections
1
Immunotherapy, Adoptive
1
Hyperthermic Intraperitoneal Chemotherapy
1
FS 069
1
Embolization, Therapeutic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Pelvic Neoplasms
×
Probiotics
×
Clear all
NCT05032027
2021-09-02
probiotics
Jiangxi Provincial Cancer Hospital
Phase NA
Unknown
40 enrolled